QUVA PHARMA THE PERFECT BLEND OF QUALITY AND INNOVATION.

Serial Number 88051706
Registration 5713217
702

Registration Progress

Application Filed
Jul 25, 2018
Under Examination
Approved for Publication
Jan 15, 2019
Published for Opposition
Jan 15, 2019
Registered
Apr 2, 2019

Trademark Image

QUVA PHARMA THE PERFECT BLEND OF QUALITY AND INNOVATION.

Basic Information

Serial Number
88051706
Registration Number
5713217
Filing Date
July 25, 2018
Registration Date
April 2, 2019
Published for Opposition
January 15, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 10, 2025
Registration
Registered
Classes
040

Rights Holder

QuVa Pharma, Inc.

03
Address
3 Sugar Creek Center Blvd, Suite 250
Sugar Land, TX 77478

Ownership History

QuVa Pharma, Inc.

Original Applicant
03
Sugar Land, TX

QuVa Pharma, Inc.

Owner at Publication
03
Sugar Land, TX

QuVa Pharma, Inc.

Original Registrant
03
Sugar Land, TX

Legal Representation

Attorney
Danielle I. Mattessich

USPTO Deadlines

Next Deadline
1248 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-04-02)
Due Date
April 02, 2029
Grace Period Ends
October 02, 2029

Application History

23 events
Date Code Type Description Documents
Jun 10, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 10, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 10, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 18, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Apr 2, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 6, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 6, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 6, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 2, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 15, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 26, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 7, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 20, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 19, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 19, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 19, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 14, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 14, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 14, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 30, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Custom manufacture of compounded sterile preparations by pharmaceutical compounders
First Use Anywhere: May 28, 2015
First Use in Commerce: May 28, 2015

Classification

International Classes
040

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"